Ruminations on the future of pharmacovigilance – new podcast out now

Perspective / 15 December 2022

After the pandemic: what were the lessons learnt for pharmacovigilance? Find out in the latest episode of the Drug Safety Matters podcast.


COVID-19 forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues.

Elena Rocca of Oslo Metropolitan University joins Drug Safety Matters host Federica Santoro in the studio for a philosophical inquiry into the lessons to be learnt from the pandemic – and what it can teach us about the science of drug safety.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

Risk Communications in Healthcare – Bridging the Gap

Start small, but think big: Trials and triumphs of #MedSafetyWeek campaigners

Stamping out drug adversity

You may also like

Start small, but think big: Trials and triumphs of #MedSafetyWeek campaigners

As we prepare for the eighth rendition of the #MedSafetyWeek campaign, we talk to some seasoned campaigners on how to run a successful campaign.

Perspective / 30 October 2023

Stamping out drug adversity

The identification of medicinal products (IDMP) standards will help make sure patients get the right medicines and make it easier to detect problems when things go wrong.

Perspective / 29 August 2022

Risk Communications in Healthcare – Bridging the Gap

Effective risk communication is a mainstay of successful pharmacovigilance, yet examples of poor risk mitigation abound. Where are we failing, and what can be done about it?

Perspective / 20 November 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more